Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning

Transplantation

Volumn 93, Issue 5, 2012, Pages 469-476

  Xu, Hong ^a   Zhu, Ziqiang ^a   Huang, Yiming ^a   Bozulic, Larry D ^a   Hussain, Lala Rukh ^a   Yan, Jun ^a   Ildstad, Suzanne T ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Bone marrow transplantation; Innate immunity; Mixed chimerism; Tolerance

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; RAPAMYCIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADAPTIVE IMMUNITY; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY TEST; GRAFT RECIPIENT; HISTOCOMPATIBILITY COMPLEX; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; INNATE IMMUNITY; MALE; MONOTHERAPY; MOUSE; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; RADIATION DOSE; T CELL DEPLETION; WHOLE BODY RADIATION; WILD TYPE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CD40 LIGAND; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNITY, HUMORAL; IMMUNITY, INNATE; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIROLIMUS; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 84857651193     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318242bddf     Document Type: Article

References (47)

1. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984;307:168.
2. Farges O, Saliba F, Farhamant H, et al. Incidence of rejection and infection after liver transplantation as a function of the primary disease: Possible influence of alcohol and polyclonal immunoglobulins. Hepatology 1996;23:240.
3. Penn I. Malignancy. Surg Clin North Am 1994;74:1247.
4. Platz KP, Mueller AR, Blumhardt G, et al. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. Transpl Int 1994;7(suppl 1): S52.
5. Vercauteren SB, Bosmans JL, Elseviers MM, et al. A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in autoimmune diseases. Kidney Int 1998;54:536.
6. Singer A, Hathcock KS, Hodes RJ. Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells. J Exp Med 1981;153:1286.
7. Zinkernagel RM, Althage A, Callahan G, et al. On the immunoincompetence of H-2 incompatible irradiated bone marrow chimeras. J Immunol 1980;124:2356.
8. Ildstad ST, Wren SM, Bluestone JA, et al. Characterization of mixed allogeneic chimeras: Immunocompetence, in vitro reactivity and genetic specificity of tolerance. J Exp Med 1985;162:231.
9. Xu H, Chilton PM, Huang Y, et al. Addition of cyclophosphamide to T-cell depletion based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation. Transplantation 2007;83:954.
10. Pilat N, Baranyi U, Klaus C, et al. Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am J Transplant 2010;10:751.
11. Zhao Y, Ohdan H, Manilay JO, et al. NK cell tolerance in mixed allogeneic chimeras. J Immunol 2003;170:5398.
12. Sharabi Y, Aksentijevich I, Sundt TM, et al. Specific tolerance induction across a xenogeneic barrier: Production of mixed rat/mouse lymphohematopoietic chimeras using a non-lethal preparative regimen. J Exp Med 1990;172:195.
13. Ohdan H, Yang YG, Swenson KG, et al. T cell and B cell tolerance to GALalpha 1,3 GAL-expressing heart xenografts is achieved in alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Transplantation 2001;71:1532.
14. Aksentijevich I, Sachs DH, Sykes M. Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen. Transplantation 1992;53:1108.
15. Kawahara T, Rodriguez-Barbosa JI, Zhao Y, et al. Global unresponsiveness as a mechanism of natural killer cell tolerance in mixed xenogeneic chimeras. Am J Transplant 2007;7:2090.
16. Boyse EA, Carswell EA, Scheid MP, et al. Tolerance of Sk-incompatible skin grafts. Nature 1973;244:441.
17. Steinmuller D, Lofgen JS. Differential survival of skin and heart allografts in radiation chimeras provides further evidence of skin histocompatibility antigens. Nature (Lond) 1974;248:796.
18. Colson YL, Wren SM, Schuchert MJ, et al. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J Immunol 1995;155:4179.
19. Colson YL, Li H, Boggs SS, et al. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J Immunol 1996;157:2820.
20. Xu H, Exner BG, Cramer DE, et al. CD8 (+), alphabeta-TCR (+), and gammadelta-TCR (+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow. J Immunol 2002;168:1636.
21. Xu H, Chilton PM, Huang Y, et al. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J Immunol 2004;172:1463.
22. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989;169:493.
23. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994;153:1087.
24. Gregori S, Giarratana N, Smiroldo S, et al. A 1alpha, 25-dihydroxyvitamin D (3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002;51:1367.
25. Khan A, Tomita Y, Sykes M. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 1996;62:380.
26. Sykes M, Szot GL, Swenson KA, et al. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 1997;3:783.
27. Qin S, Cobbold S, Benjamin R, et al. Induction of classical transplantation tolerance in the adult. J Exp Med 1989;169:779.
28. Mayumi H, Himeno K, Tanaka K, et al. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients. Transplantation 1986;42:417.
29. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993;259:974.
30. Davies JD, Leong LY, Mellor A, et al. T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996;156:3602.
31. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3:199.
32. Sanchez-Fueyo A, Weber M, Domenig C, et al. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 2002;168:2274.
33. Li XC, Wells AD, Strom TB, et al. The role of T cell apoptosis in transplantation tolerance. Curr Opin Immunol 2000;12:522.
34. Edinger M, Hoffmann P, Ermann J, et al. CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versushost disease after bone marrow transplantation. Nat Med 2003;9:1144.
35. Graca L, Le MA, Lin CY, et al. Donor-specific transplantation tolerance: The paradoxical behavior of CD4+ CD25+ T cells. Proc Natl Acad Sci U S A 2004;101:10122.
36. Jarvinen LZ, Blazar BR, Adeyi OA, et al. CD154 on the surface of CD4+ CD25+ regulatory T cells contributes to skin transplant tolerance. Transplantation 2003;76:1375.
37. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008;358:353.
38. Bernard A, Coitot S, Bremont A, et al. T and B cell cooperation: A dance of life and death. Transplantation 2005;79:S8.
39. Slifka MK, Ahmed R. Long-lived plasma cells: A mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998;10:252.
40. Xu H, Yan J, Huang Y, et al. Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization. Blood 2008;111:3266.
41. Xu H, Huang Y, Chilton PM, et al. Strategic nonmyeloablative conditioning: CD154: CD40 costimulatory blockade at primary bone marrow transplantation promotes engraftment for secondary bone marrow transplantation after engraftment failure. J Immunol 2008;181:6616.
42. Bishop GA, Hostager BS. Molecular mechanisms of CD40 signaling. Arch Immunol Ther Exp (Warsz) 2001;49:129.
43. Nemazee D, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989;337:562.
44. Hartley SB, Crosbie J, Brink R, et al. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membranebound antigens. Nature 1991;353:765.
45. Li Y, Ma L, Shen J, et al. Peripheral deletion of mature alloreactive B cells induced by costimulation blockade. Proc Natl Acad SciUSA 2007;104:12093.
46. Ohdan H, Yang YG, Shimizu A, et al. Mixed chimerism induced without lethal conditioning prevents T cell-and anti-Gal alpha 1,3 Galmediated graft rejection. J Clin Invest 1999;104:281.
47. Huang Y, Rezzoug F, Chilton PM, et al. Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: A role for host NK cells in regulating HSC engraftment. Blood 2004;104:873.